ABSTRACT Adrenal chromaffin granules contain at least 10 peptides, ranging in size from 3 to 5 kilodaltons, that yield, upon digestion with trypsin, peptides that show specific binding to opiate receptors. All are distinctly different from P-endorphin.
Although the [Met] enkephalin sequence is contained within the pituitary peptide f3-endorphin, there is now evidence to indicate that the latter is not the precursor of this opioid pentapeptide (1) (2) (3) (4) . Because [Metlenkephalin and [Leu] enkephalin are found in many tissues (brain as well as peripheral nervous system), their precursors may also be found in these tissues. The recent discovery of the enkephalins in'the adrenal medulla (5, 6) led us to examine this tissue. We found (7, 8) that bovine adrenal chromaffin granules contain many peptides that either bind directly to opiate receptors or do so after treatment with trypsin. These peptides range in size from 500 to 25,000 daltons. The larger ones, although similar in size, are distinct from the known opioid-containing peptides in the pituitary, ,B-endorphin, ,B-lipotropin, and pro-opiocortin (9) . In an earlier report, several opioid peptides in the size range of the enkephalins were shown to be present in chromaffin granule extracts; one of these was purified to homogeneity and its sequence was shown to be [Met] enkephalin-Arg6-Phe7 (10) . The identification of this heptapeptide introduced a new sequence in the opioid field and provided further evidence that [Metlenkephalin is formed via a biosynthetic pathway that does not include f3-endorphin, even though the latter also contains a [Metlenkephalin sequence (11) .
In the present study we undertook the characterization of the peptides of intermediate size [3] [4] [5] ] present in adrenal chromaffin granule extracts (7, 8) . At least 10 peptides in this range, with opiate receptor binding activity after trypsin digestion, were found, all of which are distinctly different from f3-endorphin. Two (13) . Radioimmunoassays were performed with two enkephalin antisera or 3-endorphin antiserum, as described (14) .
Reverse-phase high-performance liquid chromatography was carried out with Lichrosorb RP-18 (Ace Scientific, Edison, NJ), Ultrasphere Octyl (Altex, Berkeley, CA), or Spherisorb CN (Lab Data Control, Riviera Beach, FL). Formic acid (0.5 M) /pyridine (0.4 M) buffer, pH 4.0, was used with gradients of 1-propanol to elute the peptides and proteins (15) . An automated fluorescence detection system using fluorescamine (Hoffmann-La Roche) was used for monitoring peptides in column effluents (16) . Amino acid analysis was performed at the picomole level with a fluorescamine amino acid analyzer (17) . Sequence analyses were carried out by dansyl and Edman methods at the nanomole level, essentially as described (18, 19) , and the dansyl and phenylthiohydantoin amino acids were identified by high-performance liquid chromatography (20, 21 RESULTS The separation of peptides in extracts of bovine adrenal chromaffin granules on a Sephadex G-100 column was described in a previous report (7) . In that study, five peaks containing peptides active in the opiate radioreceptor assay or yielding Abbreviation: kDal, kilodaltons. * Present address: Tsukuba University School of Medicine, Niihari, Ibaraki, 300-31, Japan. t To whom correspondence should be addressed. 1681 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. chrosorb RP-18, Ultrasphere Octyl, or Spherisorb CN columns resolved at least 10 distinct active peptides (Fig. 2) . The relative proportions of the peptides varied from preparation to preparation, but peptides B, E, F, and I were always the major peptides present. Purification and Analysis of Opioid Peptides F and I. Fractions F-G and H-I obtained by RP-18 chromatography ( Fig. 1) were further purified on a Spherisorb column (Fig. 3) . Each fraction yielded two peaks of activity. These were digested with trypsin prior to radioreceptor assay. The major active peptides, F (Fig. 3A) and I ( Fig. 3B ) were purified to homogeneity by rechromatography on the same CN column.
Amino acid analyses of the two peptides are shown in Table  1 . Molecular weights of 3800 and 4700 for peptides F and I, respectively, were calculated from these analyses. These molecular weights are in accord with their elution positions on gel chromatography. Their compositions indicate that peptides F and I are distinct entities and that neither has any relationship to f3-endorphin (11) or to a-neoendorphin (22) ( Table 1) .
End-group analysis by the dansyl method revealed a single amino acid for each of the peptides, confirming their homogeneity. The amino terminus of peptide F is Tyr and that of peptide I is Ser.
active tryptic peptides were observed. These peaks corresponded to the following size ranges (in Dal): 20,000-24,000 (peak I), 10,000-15,000 (peak II), 7,000-10,000 (peak III), 3000-5000 (peak IV), and <1000 (peak V). The present studies were undertaken to characterize the peptides in peak IV. The fractions corresponding to peak IV from the Sephadex G-100 column were pooled and pumped directly onto a Lichrosorb RP-18 column (Fig. 1) . A number of fractions were obtained that had opiate-receptor-binding activity or yielded tryptic peptides with such activity. All of the fractions, except fraction C-D, showed much greater activity after trypsin digestion. Further chromatography of each of these fractions with Li- Tryptic Peptides Derived from Peptides F and I. For further characterization, peptides F and I were each treated with trypsin and the tryptic peptides were separated by chromatography on an Ultrasphere Octyl column (Fig. 4) . Two peaks with opiate-receptor-binding activity were obtained in the digest of peptide F, designated F-T-1 and F-T-2 according to their order of elution. The most active tryptic peptide (F-T-2) was chromatographically identical to authentic [Metlenkephalin (Fig. 4, A (Fig. 5) .
For peptide I, only one tryptic peptide with opiate-receptor-binding activity, designated I-T-2, was found. This peptide was chromatographically identical to authentic [Leujenkephalin (Fig. 4, A and C) . The amino acid composition of I-T-2 was also the same as synthetic [Leu]enkephalin (Table 2) . Although no additional active peptides were detected in the tryptic digests, a peak (I-T-1), eluting in the same position as [Met] enkephalin-Arg6, was observed. The amino acid analysis of I-T-1 was also the same as [Metlenkephalin-Arg6 (Table 2) subsequently shown to be active in the radioreceptor assay, but at far higher concentrations than were originally used. All the above data indicate that the 39-residue peptide I contains a Table 2 [Leu]enkephalin sequence that is located at the carboxyl terminus and is preceded by Lys or Arg and a [Met]enkephalin sequence in the internal portion of the peptide preceded by Lys or Arg and followed by Arg (Fig. 5) .
Radioreceptor Binding Activity and Immunoreactivity of Peptides F and I. Although amino acid analyses showed equal amounts of the tryptic peptides [Met]enkephalin and [Met]enkephalin-Lys6 in peptide F, the radioreceptor binding activity of the two tryptic fragments were clearly different ( Radioimmunoassay with an amino-terminal-directed
[Met]enkephalin antiserum showed that intact peptide F does crossreact and that there is a significant increase (1.4-fold) in crossreactivity after trypsin digestion. Intact peptide I showed crossreactivity with the above antiserum only after trypsin digestion. Both intact peptides F and I showed about 0.1% crossreactivity towards a carboxyl-terminal-directed [Leu]-enkephalin antiserum. However, after trypsin digestion, the crossreactivity of peptide I increased to 100%, whereas the crossreactivity of peptide F was unchanged. None of the 10 peptides in peak IV exhibited crossreactivity with an antiserum to 3-endorphin. Unfractionated chromaffin granule extracts were also negative to a radioimmunoassay for corticotropin. Both the radioreceptor binding assays and the radioimmunoassays are in accord with the structures shown in Fig. 5-i. [Metien- kephalin may be determined by their relative proportions in a single large precursor protein (7, 8 
